Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus. Baumert T, Urbanek-Quaing M, Cornberg M. Gut 2024 Jul 5:gutjnl-2024-332679. doi: 10.1136/gutjnl-2024-332679.

Read + Share

Amedeo Smart

Independent Medical Education

Baumert T, Urbanek-Quaing M, Cornberg M. Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus. Gut 2024 Jul 5:gutjnl-2024-332679. doi: 10.1136/gutjnl-2024-332679.
PMID: 38969491